Esperion Theraptc (ESPR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9073 -0.0127 (-1.38%) 04/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.9070 -0.0003 (-0.03%) 19:50 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,745 | -209,248 | -233,659 | -269,108 | -143,551 |
| Depreciation Amortization | 1,561 | 1,449 | 2,400 | 2,245 | 2,191 |
| Accounts receivable | -31,648 | -14,765 | -10,795 | -10,546 | -12,388 |
| Accounts payable and accrued liabilities | 12,432 | 8,678 | 5,603 | -34,099 | 23,106 |
| Other Working Capital | -60,530 | 13,675 | -3,373 | -52,513 | -4,262 |
| Other Operating Activity | 106,276 | 64,724 | 64,997 | 100,212 | 49,727 |
| Operating Cash Flow | $-23,654 | $-135,487 | $-174,827 | $-263,809 | $-85,177 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -317 | N/A | N/A | N/A | -869 |
| Purchase Of Investment | N/A | N/A | -59,897 | -50,484 | -4,420 |
| Sale Of Investment | N/A | 42,500 | 68,001 | 0 | 39,145 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -12,500 |
| Investing Cash Flow | $-317 | $42,500 | $8,104 | $-50,484 | $21,356 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 245,102 | N/A | N/A | N/A | 280,000 |
| Debt Repayment | -210,088 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 106,022 | 65,966 | 90,630 | 222,450 | 6,634 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -55,000 |
| Other Financing Activity | -54,552 | -15,506 | -58,024 | 45,773 | -29,909 |
| Financing Cash Flow | $86,484 | $50,460 | $32,606 | $268,223 | $201,725 |
| Beginning Cash Position | 82,248 | 124,775 | 258,892 | 304,962 | 167,058 |
| End Cash Position | 144,761 | 82,248 | 124,775 | 258,892 | 304,962 |
| Net Cash Flow | $62,513 | $-42,527 | $-134,117 | $-46,070 | $137,904 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,654 | -135,487 | -174,827 | -263,809 | -85,177 |
| Capital Expenditure | -317 | N/A | N/A | N/A | -869 |
| Free Cash Flow | -23,971 | -135,487 | -174,827 | -263,809 | -86,046 |